Evidence Hub

Paracetamol metabolism in Indian population

Pabba SK, Bolla S, Kandhagatla R, Chaluvadi MR, Krishna DR

Arzneimittel-Forschung, 2002

Abstract

To investigate the profile of paracetamol (CAS 103-90-2, Calpol) metabolism in Indian population and to compare with the profiles of studies conducted in other populations, a study was conducted in 100 healthy male human volunteers. After an overnight fast, the volunteers were administered an oral dose of 1 g of paracetamol, urine was collected up to 8 h and samples were analyzed by high performance liquid chromatography for the estimation of urinary recovery of paracetamol and its metabolites, i.e. sulphate, glucuronide, cysteine and mercapturate conjugates. 25.29 +/- 5.5 (mean +/- S.D.)% of sulphate conjugate, 60.55 +/- 8.5% of glucuronide conjugate, 5.05 +/- 2.1% of unchanged paracetamol, 2.76 +/- 2.4% of cysteine conjugate and 6.37 +/- 3.8% of mercapturate conjugate were recovered. The mean combined recovery of glutathione conjugates (9.13%) in Indians is found to be very high and is equal to that in Caucasians of Scotland (9.3%), which indicates that Indians are equally predisposed to hepatotoxicity as Caucasians.

How strong is the evidence?

Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free